Kathleen M Lukaszewicz1, Mahesh P Paudyal2, John R Falck2, Julian H Lombard3. 1. Department of Physiology, Medical College of Wisconsin, Milwaukee, WI, USA. 2. Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, USA. 3. Department of Physiology, Medical College of Wisconsin, Milwaukee, WI, USA. jlombard@mcw.edu.
Abstract
OBJECTIVE: The potential contribution of CYP4A enzymes to endothelial dysfunction in Dahl salt-sensitive rats was determined by comparison to SS-5BN consomic rats having chromosome 5 carrying CYP4A alleles from the BN rat introgressed into the SS genetic background. METHODS: The following experiments were performed in cerebral arteries from HS-fed SS and SS-5BN rats ± the SOD inhibitor DETC and/or the superoxide scavenger Tempol: (i) endothelial function was determined via video microscopy ± acute addition of the CYP4A inhibitor DDMS or Tempol; (ii) vascular oxidative stress was assessed with DHE fluorescence ± acute addition of DDMS, l-NAME, or PEG-SOD; and (iii) CYP4A protein levels were compared by western blotting. RESULTS: In DETC-treated SS-5BN and HS-fed SS rats, (i) DDMS or Tempol ameliorated vascular dysfunction, (ii) DDMS reduced vascular oxidative stress to control levels, (iii) chronic Tempol treatment reduced vascular CYP4A protein expression, and (iv) combined treatment with Tempol and l-NAME prevented the reduction in CYP4A protein expression in MCA of HS-fed SS rats. CONCLUSION: The CYP4A pathway plays a role in vascular dysfunction in SS rats and there appears to be a direct role of reduced NO availability due to salt-induced oxidant stress in upregulating CYP4A enzyme expression.
OBJECTIVE: The potential contribution of CYP4A enzymes to endothelial dysfunction in Dahl salt-sensitive rats was determined by comparison to SS-5BN consomic rats having chromosome 5 carrying CYP4A alleles from the BN rat introgressed into the SS genetic background. METHODS: The following experiments were performed in cerebral arteries from HS-fed SS and SS-5BNrats ± the SOD inhibitor DETC and/or the superoxide scavenger Tempol: (i) endothelial function was determined via video microscopy ± acute addition of the CYP4A inhibitor DDMS or Tempol; (ii) vascular oxidative stress was assessed with DHE fluorescence ± acute addition of DDMS, l-NAME, or PEG-SOD; and (iii) CYP4A protein levels were compared by western blotting. RESULTS: In DETC-treated SS-5BN and HS-fed SSrats, (i) DDMS or Tempol ameliorated vascular dysfunction, (ii) DDMS reduced vascular oxidative stress to control levels, (iii) chronic Tempol treatment reduced vascular CYP4A protein expression, and (iv) combined treatment with Tempol and l-NAME prevented the reduction in CYP4A protein expression in MCA of HS-fed SSrats. CONCLUSION: The CYP4A pathway plays a role in vascular dysfunction in SSrats and there appears to be a direct role of reduced NO availability due to salt-induced oxidant stress in upregulating CYP4A enzyme expression.
Authors: J Capdevila; L Parkhill; N Chacos; R Okita; B S Masters; R W Estabrook Journal: Biochem Biophys Res Commun Date: 1981-08-31 Impact factor: 3.575
Authors: A K Brzezinska; D Gebremedhin; W M Chilian; B Kalyanaraman; S J Elliott Journal: Am J Physiol Heart Circ Physiol Date: 2000-06 Impact factor: 4.733
Authors: Jennifer Cheng; Cheng-Chia Wu; Katherine H Gotlinger; Frank Zhang; John R Falck; Dubasi Narsimhaswamy; Michal Laniado Schwartzman Journal: J Pharmacol Exp Ther Date: 2009-10-19 Impact factor: 4.030
Authors: Jingli Wang; Kristopher G Maier; Richard J Roman; Lourdes De La Cruz; Jiaxuan Zhu; Lisa Henderson; Julian H Lombard Journal: Microcirculation Date: 2004 Jan-Feb Impact factor: 2.628
Authors: Shumei Meng; L Jackson Roberts; Garrick W Cason; Travis S Curry; R Davis Manning Journal: Am J Physiol Regul Integr Comp Physiol Date: 2002-09 Impact factor: 3.619
Authors: H Ischiropoulos; L Zhu; J Chen; M Tsai; J C Martin; C D Smith; J S Beckman Journal: Arch Biochem Biophys Date: 1992-11-01 Impact factor: 4.013
Authors: Kathleen M Lukaszewicz; Matthew J Durand; Jessica R C Priestley; James R Schmidt; L Adrienne Allen; Aron M Geurts; Julian H Lombard Journal: J Vis Exp Date: 2017-12-05 Impact factor: 1.355
Authors: Ahmad Hanif; Matthew L Edin; Darryl C Zeldin; Christophe Morisseau; John R Falck; Catherine Ledent; Stephen L Tilley; Mohammed A Nayeem Journal: Prostaglandins Other Lipid Mediat Date: 2017-09-07 Impact factor: 3.072
Authors: Ahmad Hanif; Matthew L Edin; Darryl C Zeldin; Christophe Morisseau; John R Falck; Mohammed A Nayeem Journal: PLoS One Date: 2017-01-05 Impact factor: 3.240
Authors: Ahmad Hanif; Matthew L Edin; Darryl C Zeldin; Christophe Morisseau; John R Falck; Mohammed A Nayeem Journal: PLoS One Date: 2017-03-22 Impact factor: 3.240